ARVC LQTS CPVT BRUGADA I42.0 I42.1 I42.2 I42.5 I42.8 I42.9
Conditions
Interventions
Group 1: Propspective observational study to collect baseline characteristics, outcome data as well as biomaterial samples to evaluate diagnostic and therapeutic strategies of patients suffering from
Sponsors
Universitätsklinikum UlmInnere Medizin II
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: acquired and/or inherited cardiomyopathy
Exclusion criteria
Exclusion criteria: Cardiomyopathy caused by: - arterial hypertension - ischemic cardiomyopathy - toxic cardiomyopathy - aortic stenosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All cause mortality | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiovascular Death, Hospitalisation, Heart failure Progression (NYHA classification), HTX, Incidence of malignant arrhythmias, Worsening of LV dysfunction | — |
Countries
Germany
Outcome results
None listed